Search
History of vaccines offers lessons on COVID-19 for pregnant women : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/history-of-vaccines-offers-lessons-on-covid-19-for-pregnant-women.html
Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine.
Researchers identify mechanism by which exercise strengthens bones and immunity: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/researchers-identify-mechanism-by-which-exercise-strengthens-bones-and-immunity.html
Scientists at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have identified the specialized environment, known as a niche, in the bone marrow where new bone and immune cells are produced.
How the brain remembers right place, right time: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/how-the-brain-remembers-right-place-right-time.html
Two studies led by UT Southwestern researchers shed new light on how the brain encodes time and place into memories.
Single-incision surgery speeds recovery for cancer patient: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/single-incision-surgery-speeds-recovery.html
A new robotic surgery device allows for all of the necessary surgical tools to be inserted through one 1-inch hole, whereas standard laparoscopic surgery requires five or six small incisions.
Study proves hepatitis C drugs reduce liver-related deaths by nearly 50%: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/hepatitis-c-drugs-reduce-liver-related-deaths.html
Antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50 percent in patients with a history of liver cancer.
Largest Texas high schools to report all concussions to statewide registry: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/texas-high-schools-report-concussions.html
Starting this fall, the biggest public high schools in Texas are required to report all sports concussions to a central database as part of one of the nation’s largest statewide endeavors to track brain injuries in youth athletics.
Three-drug combo improves lung function in most common genetic form of cystic fibrosis: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/year-2019/three-drug-combo-cystic-fibrosis.html
A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
Breaking it down: How cells degrade unwanted microRNAs : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/how-cells-degrade-unwanted-micrornas.html
UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.
Cardiac arrest survival rates fell in early years of pandemic: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/may-cardiac-arrest-survival-rates.html
Survival rates for out-of-hospital cardiac arrest (OHCA) fell during the early years of the COVID-19 pandemic, with Black and Hispanic patients experiencing larger decreases in survival, according to a study by UT Southwestern Medical Center researchers published in Resuscitation.
Drug combination could eliminate side effects of once-popular diabetes treatment: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/drug-combination-could-eliminate-diabetes-treatment-side-effects.html
Study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.